yellowish powder; odorless; easily soluble in water, slightly soluble in ethanol.
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Faquinoxaline Sodium is a synthetic intermediate primarily utilized in pharmaceutical manufacturing. Its core process involves the alkylation of quinoline derivatives followed by salt formation to enhance solubility. The compound is characterized by the molecular formula <strong>C17H18N2NaO3</strong> and holds the CAS registry number <strong>64593-07-5</strong>.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Synthesis:</strong> Serves as a key building block for antimalarial agents.</li>
<li><strong>API Manufacturing:</strong> Used in the production of specific quinoline-based active ingredients.</li>
<li><strong>R&D:</strong> Employed in research laboratories for developing novel therapeutic compounds.</li>
</ul>
<h3>Precautions</h3>
<ul>
<li><strong>Storage:</strong> Must be kept in a cool, dry place away from direct sunlight and moisture.</li>
<li><strong>Safety:</strong> Operators should wear appropriate PPE including gloves and eye protection during handling.</li>
<li><strong>Regulatory:</strong> Intended strictly for industrial synthesis; not approved for direct human administration.</li>
</ul>